AI drug discovery company

Scala Biodesign

Data as of Oct 17, 2026.

Company facts

Founded

2022

ConfirmedSource for founded (opens in new tab)
Headquarters

Israel (Tel Aviv)

ReportedSource for headquarters (opens in new tab)

Latest funding round

Round: Series A
Date: Mar 31, 2026
Amount: $16M
Lead investor: Grove Ventures

ConfirmedSource for the latest round (opens in new tab)

Drug discovery partners

1 pharma. Pharma here means a company with approved products and roughly $1B or more in annual revenue.

Boehringer Ingelheim Pharma

Protein design work, May 7, 2026

Terms not disclosed

ReportedSource for Boehringer Ingelheim (opens in new tab)

Recent news

May 7, 2026

Says it solved a Boehringer Ingelheim drug-target bottleneck in one design round

ReportedSource (opens in new tab)
Apr 16, 2026

BioCentury emerging company profile of its ScalaOS platform

ReportedSource (opens in new tab)
Mar 31, 2026

Series A: $16M

ConfirmedSource (opens in new tab)

Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.

Spot an error? Tell me and I'll fix it.